Shares of Alterity Therapeutics ATHE were up 7.8% on Jul 17 after the company announced positive interim data from the phase II ATH434-202 study evaluating its lead pipeline candidate ATH434 for ...

Long repeat sequences in the C9ORF72 gene have cropped up in cases of multiple system atrophy (MSA) and depressive pseudodementia, according to two new case studies. The findings, published in JAMA ...

Promising new research shows Alterity’s novel brain imaging tool could play a key role in diagnosing and tracking Multiple System Atrophy. Quality peer-reviewed publication highlights use of ...